Top Tweets for #DARPINS
With the 43rd Annual J.P. Morgan Healthcare Conference behind us, we wanted to share highlights of our week.
👉https://t.co/uA2syIc7hK
#radiopharmaceuticals #immunooncology #DARPins #cancerresearch #investing
We’re at the 43rd Annual JP Morgan Healthcare Conference! CEO Patrick Amstutz is presenting January 15 at 9:00am PT (6:00pm CET).
👉 https://t.co/wQLzcpQKyc
#radiopharmaceuticals #immunooncology #DARPins #cancerresearch #investing
The crystal structure of a cryo-EM imaging scaffold with rigid DARPin fusions shows that these scaffolds may act as crystallization chaperones, thus extending their utility for structural studies @ucla @IUCr #DARPins #ProteinCages #ProteinDesign https://t.co/TY2aQe8DAm
Matthew P. Agdanowski et al.: X-ray crystal structure of a designed rigidified imaging scaffold in the ligand-free conformation #DARPins #ProteinCages #ProteinDesign @ucla... #IUCr https://t.co/10PGgvTbyN
May is #NationalCancerResearchMonth. By harnessing the unique advantages of #DARPins, we are developing novel treatments for people with cancer, including MP0533, a novel tetra-specific #DARPin therapy in clinical development for patients with AML.
#NCRM24
Today at #Immuno2024, MP Sr. Scientist Natalia Venetz will present on #DARPins as a novel therapeutic modality, discussing conditionally activated DARPin therapeutics for #immunooncology, MP0533 and Switch-DARPin.
More: https://t.co/lhJQhOyois
@OGConferences
Last week our MP colleagues gathered for our Spring Social to debrief the Spring Portfolio Review and celebrate our hard work to expand #DARPins�� potential to help patients through innovative approaches.
#SwissBiotech #oncology #DARPin #RadioDARPins
NEW #JPM24 TIMESLOT: Our CEO Patrick Amstutz will be presenting on Wednesday, Jan 10th at 10:30 am PT (1:30 pm ET/7:30 pm CET).
More: https://t.co/ixDw2q8h3A
#DARPins #RadioDARPins #radiopharma #oncology #hematology #bloodcancer #AcuteMyeloidLeukemia #cancer #immunooncology
We’re looking forward to #JPM24, where our CEO Patrick Amstutz will be presenting. MP leadership will also be at the #BaaderHelvea Swiss Equities Conference & the Octavian Seminar for presentations & meetings with the Swiss investment community. https://t.co/JSrnGkiGDV
#DARPins
We had a great time presenting initial positive results from MP0533 at #ASH23 this year and connecting with so many dedicated researchers who are as committed as we are to transforming the lives of patients.
#cancer
#bloodcancer
#AML
#hematology
#immunooncology
#DARPins
We are excited to attend @UBS Swiss Equity Technology and Innovation Days and @Jefferies London Healthcare Conference this week to discuss our latest progress and opportunities for further innovation.
#DARPins
#RadioDARPins
#immunooncology
#cancer
#radioligands
#radiopharma
🚨 paper alarm 😃 Congratulations to the @goetheuni team led by Volker Doetsch, Stefan Knapp @thesgcfrankfurt , Plückthun @uzh_en, assisted by Mathias Rosenfeldt @Uni_WUE @diefenbacherl on their work on #DARPins https://t.co/Hc9e8jzW5N
Tomorrow is #ClinicalTrialsDay, and we want to thank our team members, partners, and patients who participate in #clinicaltrials so innovative medicines can reach more people in need.
Learn more: https://t.co/0ZRvGVOG5v
#ICTD23 #cancerresearch #DARPins #MP0317 #MP0533 #AML
Yesterday marked the start of #NationalCancerResearchMonth. We’re working to develop novel treatments for cancer by harnessing #DARPins unique advantages. Our #MP0317 therapeutic candidate is the perfect example of that. Learn more about how #MP0317 works in this video:
#NCRM23
At Molecular Partners, we leverage the many intrinsic advantages of #DARPins therapeutics.
Every dose received contains more molecules per gram than a larger molecule like an antibody, which provides a range of advantages including better tumor penetration.
We are searching for individuals ready to contribute to our mission to deliver #DARPins as a new class of medicines to patients across the globe.
Learn more about our collaborative and passionate working environment: https://t.co/bABXhJwflC
#BiotechJobs
This was a year full innovation and progress. We are proud of the steps we took towards delivering #DARPins as a new class of medicines for patients living with complex diseases around the world.
We look forward to all that 2023 will bring!
#DARPins can block multiple targets at once, making it difficult for a single mutation in a virus or cancer cell to break through. This could give our candidates broader efficacy and allow them to remain powerful against evolving targets.
Learn more:
https://t.co/FVMQTq19Q9
One key advantage to our DARPin® biology approach is that #DARPins are smaller in size than other types of medicines, allowing for greater tissue penetration across a wide variety of applications.
Learn more: https://t.co/xM7qnUFARx #DARPin #Biotechnology
Last Seen Hashtags on Sotwe
minuspal
Seen from Korea
mgai(*) video
Seen from Brazil
auxiouspanda
Seen from Italy
MGAI(***)**(*)*+filter:native_video
Seen from Australia
skzporn
CaughtOnCamera(((())))()***** filter:videos
Seen from United States
caughtoncamera(******)*******
Seen from United Arab Emirates
cuckold #zenci
Seen from Turkey
ชอบผ้าถุง
Seen from Thailand
gta6
Seen from Peru
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.5M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers